Skip to content

Post Covid Syndrome: Clinical Pattern and Functional Assessment

Post Covid Syndrome: Clinical Pattern and Functional Assessment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04561141
Enrollment
85
Registered
2020-09-23
Start date
2020-12-01
Completion date
2022-01-01
Last updated
2020-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

Aim(s) of the Research : 1. Identify post covid symptoms 2. prevalance of post covid syndrome among survivours

Detailed description

There is currently very limited information on the nature and prevalence of post-COVID-19 symptoms after hospital discharge. On 11th March 2020, corona virus disease 2019 (COVID-19) was declared a global pandemic by the World Health Organisation (WHO). Egypt has been one of the worst affected countries with over 101,500 confirmed cases and more than 5,696 confirmed deaths at the time of writing (17/9 2020) .1 COVID-19 is caused by the corona virus SARSCoV-2 and presents with a wide spectrum of clinical symptoms. Wu et al reported that 81% of people with COVID-19 in China presented with mild symptoms; 14% presented with symptoms of severe respiratory dysfunction; and 5% developed a critical illness with respiratory failure, septic shock, and multiple organ dysfunction or failure.2 The medium and long-term problems experienced by survivors of COVID-19 after discharge from hospital are currently unknown, but there is some emerging evidence. An Italian study followed-up 143 individuals 7 weeks post-discharge and found 53% reporting fatigue, 43% breathlessness and 27% joint pain.3 Post-discharge symptoms may also be predicted from the previous coronavirus outbreaks of Severe Acute Respiratory Syndrome (SARS) in 2002 and Middle East Respiratory Syndrome (MERS) in 2012. A meta-analysis of 28 follow-up studies found that one quarter of hospitalised survivors of SARS and MERS had reduced lung function and exercise capacity at six months post-discharge.4 At one year, post-traumatic stress disorder (PTSD), depression and anxiety, and reduced quality of life were observed Specific data concerning the rehabilitation needs of this group is therefore urgently required.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

1. patients diagnosed as covid 19 with chest ct and/or nasopharyngeal swab for covid 19 2. age 18 years old and above 3. post covid syndrome after 6 weeks

Exclusion criteria

* 1-below age of 18 2 -not confirmed cases 3. symptoms less than 6 weeks

Design outcomes

Primary

MeasureTime frameDescription
Identify post covid symptomsafter 4 weeks of diagnosisby interview questionnaire

Secondary

MeasureTime frameDescription
prevalance of post covid syndrome among survivoursafter 4 weeks of diagnosisby interview questionnaire

Contacts

Primary ContactMostafa Mahmoud
mostafamahmoud826@gmail.com0101 212 4598
Backup ContactLamia Hassan Shaban, professor
lamiashaban@yahoo.com01002681478

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026